ES2053704T3 - Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales. - Google Patents

Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.

Info

Publication number
ES2053704T3
ES2053704T3 ES88200264T ES88200264T ES2053704T3 ES 2053704 T3 ES2053704 T3 ES 2053704T3 ES 88200264 T ES88200264 T ES 88200264T ES 88200264 T ES88200264 T ES 88200264T ES 2053704 T3 ES2053704 T3 ES 2053704T3
Authority
ES
Spain
Prior art keywords
aqueous composition
monoclonal antibodies
composition consisting
stabilization method
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88200264T
Other languages
English (en)
Spanish (es)
Inventor
Gerrit Johannes Brinks
Maria Martina Francisc Mentink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2053704T3 publication Critical patent/ES2053704T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ES88200264T 1987-02-20 1988-02-15 Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales. Expired - Lifetime ES2053704T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700422 1987-02-20

Publications (1)

Publication Number Publication Date
ES2053704T3 true ES2053704T3 (es) 1994-08-01

Family

ID=19849604

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88200264T Expired - Lifetime ES2053704T3 (es) 1987-02-20 1988-02-15 Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.

Country Status (6)

Country Link
EP (1) EP0280358B1 (en:Method)
JP (1) JP2655667B2 (en:Method)
AT (1) ATE83930T1 (en:Method)
DE (1) DE3877015T2 (en:Method)
ES (1) ES2053704T3 (en:Method)
GR (1) GR3007486T3 (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
US6949355B2 (en) * 2001-10-11 2005-09-27 Aviva Biosciences Methods, compositions, and automated systems for separating rare cells from fluid samples
EP1916997B1 (en) 2005-08-05 2018-04-18 Amgen Inc. Stable aqueous protein pharmaceutical formulations and their preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4508643A (en) * 1983-02-08 1985-04-02 Baxter Travenol Laboratories, Inc. Rat antibody to hCG
US4650772A (en) * 1984-08-09 1987-03-17 Abbott Laboratories Monoclonal antibody stabilization
EP0173648A3 (en) * 1984-08-30 1988-04-27 Ciba-Geigy Ag New monoclonal antibodies to glycoconjugates, processes for their production, and applications

Also Published As

Publication number Publication date
EP0280358A1 (en) 1988-08-31
JP2655667B2 (ja) 1997-09-24
JPS63225320A (ja) 1988-09-20
DE3877015D1 (de) 1993-02-11
ATE83930T1 (de) 1993-01-15
EP0280358B1 (en) 1992-12-30
DE3877015T2 (de) 1993-05-06
GR3007486T3 (en:Method) 1993-07-30

Similar Documents

Publication Publication Date Title
DK0519926T3 (da) Transdermalt system
DE3880047D1 (de) Zusammensetzung eines zusatzes.
ATE162079T1 (de) Verwendung von antikörper enthaltenden präparationen zur immunsuppression
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
IT8622630A0 (it) Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa.
MX9203197A (es) Prodrogas de esteres que contienen sulfonato de corticisteroides.
FI822979A7 (fi) Menetelmä röntgenvarjoaineiden siedettävyyden parantamiseksi ja menetelmällä saatavia varjoaineita.
DE3684211D1 (en:Method)
IT7920592A0 (it) Determinazione di antigeni oppure di anticorpi.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
IT8123532A0 (it) Diodo zener e metodo di fabbricazione dello stesso.
DE3482800D1 (de) Herstellung von nadelkoks.
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
NO822609L (no) Stabiliseringsmetode.
DK369287D0 (da) Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
ES2053704T3 (es) Un metodo de estabilizacion de una composicion acuosa consistente en uno o mas anticuerpos monoclonales.
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
SE8104538L (sv) 1-klor-1-p-metoxibensoylformaldoxim-n-metylkarbamat
IT1215914B (it) Tampone adesivo che sviluppa profumo.
ATE51520T1 (de) Kosmetikum.
ES533775A0 (es) Procedimiento para la fabricacion de aleaciones de ferrosilicio o de silicio, que contienen estroncio
ES2160249T3 (es) Mezclas fungicidas.
SE8402615D0 (sv) Sarforband samt sett for dess framstellning
JPS6488366A (en) Iron colloid labeling antibody and preparation thereof and histocytochemical detection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 280358

Country of ref document: ES